Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Revenues:        
Revenues $ 1,423,964 $ 1,097,311 $ 4,346,831 $ 3,310,469
Costs and expenses:        
Costs of revenues 590,158 486,945 1,828,017 1,276,592
Research and development 215,433 184,887 646,764 504,320
Selling, general and administrative 185,760 182,184 566,358 409,084
Goodwill impairment 256,649 0 256,649 0
Interest expense 39,231 31,187 120,053 84,087
Loss on extinguishment of debt 22,538 0 22,538 0
Other expense (income), net (1,004) (9,282) (5,190) (28,535)
Income before income taxes 115,199 221,390 911,642 1,064,921
Provision for income taxes 37,190 28,745 106,932 107,232
Net income 78,009 192,645 804,710 957,689
Less: Net loss attributable to non-controlling interest (443) (83) (822) (83)
Net income attributable to KLA $ 78,452 $ 192,728 $ 805,532 $ 957,772
Net income per share attributable to KLA        
Basic (in dollars per share) $ 0.50 $ 1.23 $ 5.12 $ 6.20
Diluted (in dollars per share) $ 0.50 $ 1.23 $ 5.08 $ 6.17
Weighted-average number of shares:        
Basic (in shares) 156,067 156,349 157,356 154,561
Diluted (in shares) 157,172 157,182 158,586 155,310
Product        
Revenues:        
Revenues $ 1,051,096 $ 793,224 $ 3,253,621 $ 2,474,652
Service        
Revenues:        
Revenues $ 372,868 $ 304,087 $ 1,093,210 $ 835,817